During the past decade, First OC Dermatology conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 29 clinical trials were completed, i.e. on average, 46% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 29 clinical trials were completed. i.e. 69% of trials that started reached the finish line.

Out of the total clinical trials conducted in "First OC Dermatology" #1 sponsor was "Eli Lilly and Company" with 17 trials, followed by "Pfizer" with 9 trials sponsored, "Incyte Corporation" with 8 trials sponsored, "Amgen" with 7 trials sponsored and "Biofrontera Bioscience GmbH" with 7 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "First OC Dermatology" #1 collaborator was "Dermira, Inc." with 4 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "First OC Dermatology" are "Atopic Dermatitis" (24 trials), "Plaque Psoriasis" (10 trials), "Psoriasis" (9 trials), "Alopecia Areata" (4 trials) and "Dermatitis, Atopic" (4 trials). Many other conditions were trialed in "First OC Dermatology" in a lesser frequency.

Most popular intervention types in "First OC Dermatology" are "Drug" (54 trials), "Other" (8 trials), "Biological" (6 trials), "Combination Product" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Lebrikizumab" (6 trials), "Vehicle" (5 trials), "Ruxolitinib cream" (4 trials) and "Apremilast" (3 trials). Other intervention names were less common.

The vast majority of trials in "First OC Dermatology" are 62 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "First OC Dermatology". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in First OC Dermatology, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in First OC Dermatology, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".